(Q44695391)

5 December 2017

title

Effect of the combination of naltrexone and acamprosate on alcohol intake in mice (English)

1 reference

5 December 2017

0 references

Sung-Gon Kim

1

1 reference

5 December 2017

Byeung-Deuk Han

2

1 reference

5 December 2017

Je-Min Park

3

1 reference

5 December 2017

Myung-Jung Kim

4

1 reference

5 December 2017

Michael F Stromberg

5

1 reference

5 December 2017

publication date

1 February 2004

1 reference

Psychiatry and Clinical Neurosciences

5 December 2017

published in

1 reference

5 December 2017

volume

58

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

30-36

1 reference

The efficacy of disulfiram: a review of outcome studies

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Acamprosate in alcohol dependence: how does it work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Endogenous opioid systems and alcohol addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Effect of ethanol on extracellular 5-HT and glutamate in the nucleus accumbens and prefrontal cortex: comparison between the Lewis and Fischer 344 rat strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

The delta 2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Blockade of delta-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Naltrexone and alcohol dependence. Role of subject compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Comparison of acamprosate and placebo in long-term treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Combination pharmacotherapy: a mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

Biochemical evidence for overlapping neocortical and allocortical glutamate projections to the nucleus accumbens and rostral caudatoputamen in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2004.01189.X

10.1111/J.1440-1819.2004.01189.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference